Replies to post #75078 on Avid Bioservices Inc (CDMO)

[Protector]

Where where you lately!

One thing for sure, we are off the radar. Neither institutions, nor new investors can find us, or hear our story.

Check the % of Institutional and big investors progress over the last 18 months, then come again with the above statement.

Check the increase in visibility to the investor community by means of Dog& Pony shows over that same period and check the quality of some that have been added, then come again with the above statement.

Check the volume of this stock over the past period and tell us who consistently can generate that volume and not be in the Investment or trading business, then come again with the above statement.

Check the opportunities given to Thorpe to become keynote speaker in international conferences, then come again with the above statement.

Check how many BP personnel found the way to Peregrine and now work in the off the radar company, then come again with the above statement.

Check how this boards is populated and the amount of messages that are posted in the Peregrine section compared to many (not all of course) BP, then come again with the above statement.

Check how the e-magazines, twitter channels and boards with followers are getting more and more involved with the stock as reported here, in bad or in good, for this of the radar stock, then come again with the above statement.

And finally read the board back and count the number of II that added us, even if only a couple of thousand shares, and explain how they find us if it isn't that we attract attention, then come again with the above statement.

[entdoc]

hey rrdog and until 2k, I've just always thought that PPHM was an R&D front for Roche. It makes every non-sequitur we've talked about here make sense, including a royal stockholder screving when the curtain comes down on this long-running charade. They've succeeded in beating us senseless until almost everyone here would go for a 5:1 "premium". I'm with until2k:I'll continue to follow the science.